Brief: Austar Lifesciences Says Group Expects Decrease In HY Loss Attributable
24/07/2018 12:30
July 24 (Reuters) - Austar Lifesciences Ltd 6118.HK :
* GROUP FOR SIX MONTHS ENDED 30 JUNE 2018 EXPECTED TO RECORD
A
DECREASE IN LOSS ATTRIBUTABLE
* EXPECTED RESULT DUE TO AN INCREASE IN REVENUE AND GROSS
PROFIT
FROM BUSINESS SEGMENT OF LIFE SCIENCE CONSUMABLES
Source text for Eikon: ID:nHKS8bXV1t
Further company coverage: 6118.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director